Shree Siddhivinayak Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-05-2024
- Paid Up Capital ₹ 0.10 M
as on 29-05-2024
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2016)
- Profit 5.60%
(FY 2016)
- Ebitda 5.60%
(FY 2016)
- Net Worth -13.79%
(FY 2016)
- Total Assets -0.57%
(FY 2016)
About Shree Siddhivinayak Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pritesh Patil and Ajay Deshmukh serve as directors at the Company.
- CIN/LLPIN
U24230MH2008PTC182538
- Company No.
182538
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shree Siddhivinayak Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pritesh Patil  | Director | 29-Sep-2017 | Current |
| Ajay Deshmukh | Director | 29-Sep-2017 | Current |
Financial Performance and Corporate Structure Insights of Shree Siddhivinayak Pharma.
Shree Siddhivinayak Pharma Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 5.6% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Siddhivinayak Pharma?
In 2017, Shree Siddhivinayak Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Haridra Laxmi Krishival Private LimitedActive 16 years 9 monthsPritesh Patil and Ajay Deshmukh are mutual person
- Eco-Frenzy Solar Solutions Private LimitedActive 8 years 6 months
Pritesh Patil and Ajay Deshmukh are mutual person
- Enviro Green Energy Technologies Private LimitedActive 8 years 6 months
Pritesh Patil and Ajay Deshmukh are mutual person
- Ggc Sugar And Allied Industries Private LimitedActive 8 years 2 months
Pritesh Patil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shree Siddhivinayak Pharma?
Unlock and access historical data on people associated with Shree Siddhivinayak Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Siddhivinayak Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Siddhivinayak Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
